Journal Article Review Ppublish 51 citations
PubMed: 39059357 DOI: 10.1016/j.cell.2024.06.029
Diabetes mellitus-Progress and opportunities in the evolving epidemic.
Cell 187(15):3789-3820
Authors: E Dale Abel, Anna L Gloyn, Carmella Evans-Molina, Joshua J Joseph, Shivani Misra, Utpal B Pajvani, Judith Simcox, Katalin Susztak, Daniel J Drucker
Affiliations
- Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
- Department of Pediatrics, Division of Endocrinology & Diabetes, Department of Genetics, Stanford Diabetes Research Center, Stanford University School of Medicine, Stanford, CA, USA.
- Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.
- Division of Endocrinology, Diabetes and Metabolism, The Ohio State University College of Medicine, Columbus, OH, USA.
- Department of Metabolism, Digestion and Reproduction, Imperial College London, and Imperial College NHS Trust, London, UK.
- Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
- Howard Hughes Medical Institute, Department of Biochemistry, University of Wisconsin-Madison, Madison, WI, USA.
- Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
- Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada; Department of Medicine, University of Toronto, Toronto, ON, Canada.
Abstract
Diabetes, a complex multisystem metabolic disorder characterized by hyperglycemia, leads to complications that reduce quality of life and increase mortality. Diabetes pathophysiology includes dysfunction of beta cells, adipose tissue, skeletal muscle, and liver. Type 1 diabetes (T1D) results from immune-mediated beta cell destruction. The more prevalent type 2 diabetes (T2D) is a heterogeneous disorder characterized by varying degrees of beta cell dysfunction in concert with insulin resistance. The strong association between obesity and T2D involves pathways regulated by the central nervous system governing food intake and energy expenditure, integrating inputs from peripheral organs and the environment. The risk of developing diabetes or its complications represents interactions between genetic susceptibility and environmental factors, including the availability of nutritious food and other social determinants of health. This perspective reviews recent advances in understanding the pathophysiology and treatment of diabetes and its complications, which could alter the course of this prevalent disorder.
MeSH
Diabetes Mellitus, Cells, Food, Cell Biology, Environment, Epidemics
Cited by
- Longitudinal effects of Johnson & Johnson COVID-19 vaccination on metabolic biomarkers in type 2 diabetes mellitus in Ethiopia. World J Diabetes, 2025
- Serine palmitoyltransferase-mediated de novo sphingolipid biosynthesis is required for normal insulin production and glucose tolerance. bioRxiv, 2025
- The Intersection of SARS-CoV-2 and Diabetes. Microorganisms, 2025
- The Relationship Between Computerized Face and Tongue Image Segmentation and Metabolic Parameters in Patients with Type 2 Diabetes Based on Machine Learning. Diabetes Metab Syndr Obes, 2024
- Clinical metabolomics in type 2 diabetes mellitus: from pathogenesis to biomarkers. Front Endocrinol (Lausanne), 2025
- Insights into circulating CEACAM1 in insulin clearance and disease progression: Evidence from the Portuguese PREVADIAB2 study. Eur J Clin Invest, 2024
- Application and Progression of Single-Cell RNA Sequencing in Diabetes Mellitus and Diabetes Complications. J Diabetes Res, 2025
- Effect of Imeglimin on mitochondrial function in patients with type 2 diabetes mellitus: a prospective cohort study. Front Endocrinol (Lausanne), 2025
- Clinical value of preoperative oral carbohydrate loading in patients with diabetes: a cross-sectional study. BMC Anesthesiol, 2025
- Recovery time of diabetic ketoacidosis in Africa: Systematic review and meta-analysis. Metabol Open, 2025
- Synthesis, characterization, and in vitro and in silico α-glucosidase inhibitory evolution of novel N'-(2-cyclopentyl-2-phenylacetyl)cinnamohydrazide derivatives. RSC Adv, 2025
- Type 2 diabetes mellitus - conventional therapies and future perspectives in innovative treatment. Biochem Biophys Rep, 2025
- Causal Associations Between Pre-Pregnancy Diabetes Mellitus and Pre-Eclampsia Risk: Insights from a Mendelian Randomization Study. Healthcare (Basel), 2025
- Exploring the effect of dapagliflozin on coronary inflammation in type 2 diabetes patients based on the coronary artery perivascular fat attenuation index. Cardiovasc Diabetol, 2025
- Hydrogen sulfide: an emerging gasotransmitter involved in the survival of pancreatic islets during diabetes therapy. Med Gas Res, 2024
- Global burden of diabetes mellitus 1990-2021: epidemiological trends, geospatial disparities, and risk factor dynamics. Front Endocrinol (Lausanne), 2025
- Exploring the role of curcumin in mitigating oxidative stress to alleviate lipid metabolism disorders. Front Pharmacol, 2025
- Bibliometric mapping of diabetes mellitus and sarcopenia research: hotspots and emerging trends. Front Med (Lausanne), 2025
- Global research trends in the relationship between diabetic cardiomyopathy and mitochondria: a bibliometric analysis. Hereditas, 2025
- Glycolytic disruption restricts Drosophila melanogaster larval growth via the cytokine Upd3. PLoS Genet, 2025